Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease

摘要

BACKGROUND. Hepatic de novo lipogenesis (DNL) is elevated in nonalcoholic fatty liver disease (NAFLD). Improvements in hepatic fat by dietary sugar reduction may be mediated by reduced DNL, but data are limited, especially in children. We examined the effects of 8 weeks of dietary sugar restriction on hepatic DNL in adolescents with NAFLD and correlations between DNL and other metabolic outcomes. METHODS. Adolescent boys with NAFLD (n = 29) participated in an 8-week, randomized controlled trial comparing a diet low in free sugars versus their usual diet. Hepatic DNL was measured as percentage contribution to plasma triglyceride palmitate using a 7-day metabolic labeling protocol with heavy water. Hepatic fat was measured by magnetic resonance imaging-proton density fat fraction. RESULTS. Hepatic DNL was significantly decreased in the treatment group (from 34.6 to 24.1) versus the control group (33.9 to 34.6) (adjusted week 8 mean difference: -10.6 95 CI: -19.1, -2.0), which was paralleled by greater decreases in hepatic fat (25.5 to 17.9 vs. 19.5 to 18.8) and fasting insulin (44.3 to 34.7 vs. 35.5 to 37.0 μIU/ mL). Percentage change in DNL duringthe intervention correlated significantly with changes in free-sugar intake (r = 0.48, P = 0.011), insulin (r = 0.40, P = 0.047), and alanine aminotransferase (ALT) (r = 0.39, P= 0.049), but not hepatic fat (r= 0.13, P = 0.532). CONCLUSION. Our results suggest that dietary sugar restriction reduces hepatic DNL and fasting insulin, in addition to reductions in hepatic fat and ALT, among adolescents with NAFLD. These results are consistent with the hypothesis that hepatic DNL is a critical metabolic abnormality linking dietary sugar and NAFLD.